SHIRE MOVETIS N V has a total of 16 patent applications. Its first patent ever was published in 1995. It filed its patents most often in Canada, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are PHARMACIA ITALIA S, MOUNT COOK BIOSCIENCES INC and SCHERING AKTI ENGESELLSCHAFT.
# | Country | Total Patents | |
---|---|---|---|
#1 | Canada | 3 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 1 | |
#5 | Hungary | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | Romania | 1 | |
#10 | Singapore | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Thielemans Leen | 10 |
#2 | Meulemans Ann | 10 |
#3 | Cools Marina | 8 |
#4 | Keller Erik | 8 |
#5 | Mezine Igor Alexnadrovich | 8 |
#6 | Lavrijsen Karel | 8 |
#7 | Van Geffen Maarten | 6 |
#8 | Schuurkes Jan | 2 |
#9 | Embrechts Roger Carolus Augusta | 2 |
#10 | De Maeyer Joris | 2 |
Publication | Filing date | Title |
---|---|---|
EP2680825A1 | Prucalopride oral solution | |
MX2012003486A | [1,4]-benzodiazepines as vasopressin v2 receptor antagonists. | |
AU2010209678A1 | 5-HT4 inhibitors for treating airway diseases, in particular asthma |